A virus-derived microRNA targets immune response genes during SARS-CoV-2 infection.
A virus-derived microRNA targets immune response genes during SARS-CoV-2 infection.
复制标题
DOI:
10.15252/embr.202154341
复制
发表时间:
2022-02-03
期刊:
影响因子:
7.7
通讯作者:
Cecere G
中科院分区:
文献类型:
--
作者:
Singh M;Chazal M;Quarato P;Bourdon L;Malabat C;Vallet T;Vignuzzi M;van der Werf S;Behillil S;Donati F;Sauvonnet N;Nigro G;Bourgine M;Jouvenet N;Cecere G
SARS‐CoV‐2 infection results in impaired interferon response in patients with severe COVID‐19. However, how SARS‐CoV‐2 interferes with host immune responses is incompletely understood. Here, we sequence small RNAs from SARS‐CoV‐2‐infected human cells and identify a microRNA (miRNA) derived from a recently evolved region of the viral genome. We show that the virus‐derived miRNA produces two miRNA isoforms in infected cells by the enzyme Dicer, which are loaded into Argonaute proteins. Moreover, the predominant miRNA isoform targets the 3′UTR of interferon‐stimulated genes and represses their expression in a miRNA‐like fashion. Finally, the two viral miRNA isoforms were detected in nasopharyngeal swabs from COVID‐19 patients. We propose that SARS‐CoV‐2 can potentially employ a virus‐derived miRNA to hijack the host miRNA machinery, which could help to evade the interferon‐mediated immune response. SARS‐CoV‐2 produces two miRNAs derived from a conserved stem‐loop structure of the ORF‐7a transcript in a Dicer‐dependent manner. These virus‐derived miRNAs interact with host Argonaute and can repress host innate immune response genes in cultured cells.